Skip to main content

Table 1 Longitudinal measurements of plasma levels of CA9 in patients with clear cell RCC undergoing curative or debulking nephrectomy

From: Blood Levels of Carbonic Anhydrase 9 Correlate with Clear Cell Renal Cell Carcinoma Activity

Patient

Sex

Pre

Post

6 months

12 months

2 years

Stage

Follow-up

104

M

381.26

154.65

  

201.2812444

pT1b Nx Mx

NED 5/10/07

4/21/2005

6/23/2005

  

5/10/2007

  

176

M

431.69

751.74

1,087.08

  

T1bN2M1

Tx with SU/DP

12/13/06

2/15/07

Post 5/10/07

    

186

M

No pre

430.28

70.55

52.43

 

T3bN2M0, DN-1/07

Tx with SU + G/PR

 

2/27/07

Post 4/19/07

Post 5/10/07

   

113

M

394.42

359.81

  

860.55

T2N2M1 on presentation

Tx with SU/SD

7/8/05

8/22/05

  

3/29/07

  

136

F

1,032.19

1,035.50

2,711.44

2,855.51

 

T3aN0M1

SU (6/06)/SD

3/30/2006

5/11/2006

10/24/2006

2/27/2007

   

139

F

143.28

 

201.90

  

T3aN0M0

NED (12/06)

5/1/06

 

12/19/2006

    

146

M

201.90

208.27

203.17

  

T1bN0M0

NED

6/8/2006

8/24/2006

1/16/2007

    
  1. SU Treatment with sutent, G treatment with gemcitabine, PR partial response, SD stable disease, DP disease progression, NED no evidence of disease